To amend the Federal Food, Drug, and Cosmetic Act to authorize a program to support the adoption of, and improve the development of, innovative approaches to pharmaceutical product design and manufacturing, and for other purposes.
Drug Manufacturing Innovation Act of 2022
This bill requires the Food and Drug Administration to establish a program to support innovative approaches to pharmaceutical product design and manufacturing, including through grants, regulatory guidance, and working groups.
Take Action
Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.